Prolonged shedding of human coronavirus in hematopoietic cell transplant recipients: Risk factors and viral genome evolution

Journal of Infectious Diseases

Volumn 216, Issue 2, 2017, Pages 203-209

  Ogimi, Chikara ^a,b,c   Greninger, Alexander L ^a,b   Waghmare, Alpana A ^a,b,c   Kuypers, Jane M ^a,b   Shean, Ryan C ^a,b   Xie, Hu ^a   Leisenring, Wendy M ^a,b   Stevens Ayers, Terry L ^a   Jerome, Keith R ^a,b   Englund, Janet A ^b,c   Boeckh, Michael ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

Genome evolution; Hematopoietic cell transplant; Human coronavirus; Shedding; Whole genome sequencing

Indexed keywords

STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORONAVIRIDAE; DRUG MEGADOSE; FEMALE; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; METAGENOMICS; MOLECULAR EVOLUTION; MYELOABLATIVE CONDITIONING; NEXT GENERATION SEQUENCING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STRAIN IDENTIFICATION; VIRUS DETECTION; VIRUS GENOME; VIRUS LOAD; VIRUS SHEDDING; CLASSIFICATION; CORONAVIRUS INFECTIONS; GENETICS; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS; STATISTICAL MODEL; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CORONAVIRUS; CORONAVIRUS INFECTIONS; FEMALE; GENOME, VIRAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; STEROIDS; VIRAL LOAD; VIRUS SHEDDING; YOUNG ADULT;

EID: 85028445299     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jix264     Document Type: Article

References (33)

1. Renaud C, Xie H, Seo S, et al. Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients. Biol Blood Marrow Transplant 2013; 19:1220-6.
2. Chemaly RF, Shah DP, Boeckh MJ. Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies. Clin Infect Dis 2014; 59(suppl 5):S344-51.
3. Lo MS, Lee GM, Gunawardane N, Burchett SK, Lachenauer CS, Lehmann LE. The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy. Pediatr Transplant 2013; 17:133-43.
4. Weigt SS, Gregson AL, Deng JC, Lynch JP 3rd, Belperio JA. Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients. Semin Respir Crit Care Med 2011; 32:471-93.
5. Renaud C, Campbell AP. Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients. Curr Opin Infect Dis 2011; 24:333-43.
6. Milano F, Campbell AP, Guthrie KA, et al. Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients. Blood 2010; 115:2088-94.
7. Ogimi C, Waghmare AA, Kuypers JM, et al. Clinical significance of human coronavirus in bronchoalveolar lavage samples from hematopoietic cell transplant recipients and patients with hematologic malignancies. Clin Infect Dis 2017; 64:1532-9.
8. Campbell AP, Guthrie KA, Englund JA, et al. Clinical outcomes associated with respiratory virus detection before allogeneic hematopoietic stem cell transplant. Clin Infect Dis 2015; 61:192-202.
9. Kuypers J, Martin ET, Heugel J, Wright N, Morrow R, Englund JA. Clinical disease in children associated with newly described coronavirus subtypes. Pediatrics 2007; 119:e70-6.
10. Greninger AL, Zerr DM, Qin X, et al. Rapid metagenomic next-generation sequencing during an investigation of hospital-acquired human parainfluenza virus 3 infections. J Clin Microbiol 2017; 55:177-82.
11. Kearse M, Moir R, Wilson A, et al. Geneious basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 2012; 28:1647-9.
12. Bacigalupo A, Ballen K, Rizzo D, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009; 15:1628-33.
13. Vijgen L, Keyaerts E, Moës E, et al. Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event. J Virol 2005; 79:1595-604.
14. Pyrc K, Dijkman R, Deng L, et al. Mosaic structure of human coronavirus NL63, one thousand years of evolution. J Mol Biol 2006; 364:964-73.
15. Arabi YM, Arifi AA, Balkhy HH, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med 2014; 160:389-97.
16. Leung GM, Hedley AJ, Ho LM, et al. The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med 2004; 141:662-73.
17. Chan JW, Ng CK, Chan YH, et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax 2003; 58:686-9.
18. Chong YP, Song JY, Seo YB, Choi JP, Shin HS; Rapid Response Team. Antiviral treatment guidelines for Middle East respiratory syndrome. Infect Chemother 2015; 47:212-22.
19. Mo Y, Fisher D. A review of treatment modalities for Middle East respiratory syndrome. J Antimicrob Chemother 2016; 71:3340-50.
20. Center for Drug Evaluation and Research, US Food and Drug Administration. Guidance for industry influenza, developing drugs for treatment and/or prophylaxis. Silver Spring, MD: FDA, 2009:27.
21. Patel P, Bush T, Kojic EM, et al. Duration of influenza virus shedding among HIVinfected adults in the cART era, 2010-2011. AIDS Res Hum Retroviruses 2016; 32:1180-6.
22. Hu Q, Lu R, Peng K, et al. Prevalence and genetic diversity analysis of human coronavirus OC43 among adult patients with acute respiratory infections in Beijing, 2012. PLoS One 2014; 9:e100781.
23. Kin N, Miszczak F, Lin W, Gouilh MA, Vabret A, Consortium E. Genomic analysis of 15 human coronaviruses OC43 (HCoV-OC43s) circulating in France from 2001 to 2013 reveals a high intra-specific diversity with new recombinant genotypes. Viruses 2015; 7:2358-77.
24. Lau SK, Lee P, Tsang AK, et al. Molecular epidemiology of human coronavirus OC43 reveals evolution of different genotypes over time and recent emergence of a novel genotype due to natural recombination. J Virol 2011; 85:11325-37.
25. Park D, Huh HJ, Kim YJ, et al. Analysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirus. Cold Spring Harb Mol Case Stud 2016; 2:a001214.
26. Do LA, Wilm A, Van Doorn HR, et al. Direct whole-genome deep-sequencing of human respiratory syncytial virus A and B from Vietnamese children identifies distinct patterns of inter-and intra-host evolution. J Gen Virol 2015; 96:3470-83.
27. de Jong MD, Tran TT, Truong HK, et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 2005; 353:2667-72.
28. Rath B, von Kleist M, Tief F, et al. Virus load kinetics and resistance development during oseltamivir treatment in infants and children infected with influenza A (H1N1) 2009 and influenza B viruses. Pediatr Infect Dis J 2012; 31:899-905.
29. Mehta T, McGrath E, Bheemreddy S, et al. Detection of oseltamivir resistance during treatment of 2009 H1N1 influenza virus infection in immunocompromised patients: utility of cycle threshold values of qualitative real-time reverse transcriptase PCR. J Clin Microbiol 2010; 48:4326-8.
30. Grad YH, Newman R, Zody M, et al. Within-host whole-genome deep sequencing and diversity analysis of human respiratory syncytial virus infection reveals dynamics of genomic diversity in the absence and presence of immune pressure. J Virol 2014; 88:7286-93.
31. Posthuma CC, Te Velthuis AJ, Snijder EJ. Nidovirus RNA polymerases: complex enzymes handling exceptional RNA genomes. Virus Res 2017. doi:10.1016/j.virusres.2017.01.023.
32. Smith EC, Denison MR. Coronaviruses as DNA wannabes: A new model for the regulation of RNA virus replication fidelity. PLoS Pathog 2013; 9:e1003760.
33. Smith EC, Sexton NR, Denison MR. Thinking outside the triangle: replication fidelity of the largest RNA viruses. Annu Rev Virol 2014; 1:111-32.